Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/30/16
End: 06/30/20
Due: 06/30/21
Phase: N/A
Priority: Normal
Start: 08/31/15
End: 11/30/16
Due: 11/30/17
Phase: N/A
Priority: Normal
Start: 11/30/09
End: 09/30/12
Due: 09/30/13
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Efficacy of VAS203 (Ronopterin) in Patients With Moderate and Severe Traumatic Brain Injury | NCT02794168 | veriNOS operations GmbH | user2@example.com | None | 2016-06-30 | 2020-06-30 | 2021-06-30 | - | - | 2025-07-14 |
| Effects of the NO-synthase Inhibitor VAS203 on Renal Function in Healthy Volunteers | NCT02992236 | veriNOS operations GmbH | user2@example.com | None | 2015-08-31 | 2016-11-30 | 2017-11-30 | - | - | 2025-07-14 |
| Phase 2 a Study to Assess Safety and Pharmacokinetics of VAS203 in Patients With Traumatic Brain Injury | NCT02012582 | veriNOS operations GmbH | user2@example.com | None | 2009-11-30 | 2012-09-30 | 2013-09-30 | - | - | 2025-07-14 |